A healthy 10-year-old male presents for evaluation with a 3-year history of an asymptomatic and progressive, mildly pruritic rash over his head and trunk. The first lesion appeared on his back 3 years ...
The FDA approved insulin icodec-abae for children 10+ with T2D, based on adult ONWARDS data and a single-dose pediatric pharmacokinetic study. Children and adolescents 10 years and older with type 2 ...
A Mott Poll of 2,027 parents found 81% say having a baby costs too much; 73% strongly back state paid leave around birth.
New AAP guidance recommends age-specific iron deficiency screening, updated ferritin thresholds, and simplified treatment strategies for children. Iron deficiency remains one of the most common ...
New AAP guidance highlights layered drowning prevention strategies, including supervision, swim lessons, CPR training, and pool fencing. Drowning remains a leading cause of unintentional injury death ...
Findings from phase 3 SHORE and COAST 2 trials showed amlitelimab met key efficacy end points in moderate to severe atopic dermatitis, supporting planned regulatory submissions. Sanofi announced ...
Katie McMahon and Kathy Baylis, PhD, discuss research showing that prenatal exposure to hot, humid conditions has significant effects on child growth and health.
Effective immediately, the updated US childhood vaccine schedule will reduce the number of recommended vaccines for all children to 11 diseases, down from 18. On January 5, 2026, the CDC updated the ...
Youth suicides by sodium nitrite/nitrate are rising, highlighting prevention gaps and opportunities for early medical and public health intervention. An emerging suicide method involving ingestion of ...
Explore essential resources and toolkits for managing the ongoing stimulant medication shortage affecting ADHD treatment and patient care. Drug shortages have historically led to economic impacts, ...
A look back at the most important FDA approvals, clinical research, and expert perspectives shaping pediatric health care in the first half of 2025. The first half of 2025 has been marked by ...
Flovent was discontinued in January 2024 due to the manufacturer electing to produce only an authorized generic version of the medication. Inhaled corticosteroids (ICS) are a mainstay in reducing ...